These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 23114547)

  • 21. Modeling survival in colon cancer: a methodological review.
    Ahmed FE; Vos PW; Holbert D
    Mol Cancer; 2007 Feb; 6():15. PubMed ID: 17295918
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cumulative incidence in competing risks data and competing risks regression analysis.
    Kim HT
    Clin Cancer Res; 2007 Jan; 13(2 Pt 1):559-65. PubMed ID: 17255278
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methods to Analyze Time-to-Event Data: The Cox Regression Analysis.
    Abd ElHafeez S; D'Arrigo G; Leonardis D; Fusaro M; Tripepi G; Roumeliotis S
    Oxid Med Cell Longev; 2021; 2021():1302811. PubMed ID: 34887996
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Graphing survival curve estimates for time-dependent covariates.
    Schultz LR; Peterson EL; Breslau N
    Int J Methods Psychiatr Res; 2002; 11(2):68-74. PubMed ID: 12459796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Survival Analysis: Where, Why, What and How?
    Indrayan A; Tripathi CB
    Indian Pediatr; 2022 Jan; 59(1):74-79. PubMed ID: 34047720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Survival analysis and regression models.
    George B; Seals S; Aban I
    J Nucl Cardiol; 2014 Aug; 21(4):686-94. PubMed ID: 24810431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of methods for estimating the attributable risk in the context of survival analysis.
    Gassama M; Bénichou J; Dartois L; Thiébaut AC
    BMC Med Res Methodol; 2017 Jan; 17(1):10. PubMed ID: 28114895
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prediction in censored survival data: a comparison of the proportional hazards and linear regression models.
    Heller G; Simonoff JS
    Biometrics; 1992 Mar; 48(1):101-15. PubMed ID: 1581480
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Statistical methods in epidemiology. IX. Survival (failure-time) models.
    Rigby AS; Zhang J; Goode KM
    Disabil Rehabil; 2010; 32(4):267-72. PubMed ID: 20055565
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [A new perspective of survival data on clinical epidemiology: introduction of competitive risk model].
    Nie ZQ; Ou YQ; Qu YJ; Yuan HY; Liu XQ
    Zhonghua Liu Xing Bing Xue Za Zhi; 2017 Aug; 38(8):1127-1131. PubMed ID: 28847068
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Carbonic anhydrase enzymes II, VII, IX and XII in colorectal carcinomas.
    Viikilä P; Kivelä AJ; Mustonen H; Koskensalo S; Waheed A; Sly WS; Pastorek J; Pastorekova S; Parkkila S; Haglund C
    World J Gastroenterol; 2016 Sep; 22(36):8168-77. PubMed ID: 27688658
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    de Glas NA; Kiderlen M; Vandenbroucke JP; de Craen AJ; Portielje JE; van de Velde CJ; Liefers GJ; Bastiaannet E; Le Cessie S
    J Natl Cancer Inst; 2016 May; 108(5):. PubMed ID: 26614095
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prognostic factors for clinical outcomes according to time after direct pulp capping.
    Cho SY; Seo DG; Lee SJ; Lee J; Lee SJ; Jung IY
    J Endod; 2013 Mar; 39(3):327-31. PubMed ID: 23402502
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion.
    Brown JB; Cohen MJ; Minei JP; Maier RV; West MA; Billiar TR; Peitzman AB; Moore EE; Cushieri J; Sperry JL;
    J Trauma Acute Care Surg; 2012 Aug; 73(2):358-64; discussion 364. PubMed ID: 22846940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Decrease in long-term survival for hospitalized patients with community-acquired pneumonia.
    Bordon J; Wiemken T; Peyrani P; Paz ML; Gnoni M; Cabral P; Venero Mdel C; Ramirez J;
    Chest; 2010 Aug; 138(2):279-83. PubMed ID: 20382718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analyzing sickness absence with statistical models for survival data.
    Christensen KB; Andersen PK; Smith-Hansen L; Nielsen ML; Kristensen TS
    Scand J Work Environ Health; 2007 Jun; 33(3):233-9. PubMed ID: 17572833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Statistical primer: basics of survival analysis for the cardiothoracic surgeon.
    Thuijs DJFM; Hickey GL; Osnabrugge RLJ
    Interact Cardiovasc Thorac Surg; 2018 Jul; 27(1):1-4. PubMed ID: 29800119
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nodal staging score: a tool for survival prediction of node-negative bladder cancer.
    Ku JH; Kim HH; Kwak C
    Urol Oncol; 2013 Nov; 31(8):1731-6. PubMed ID: 23141779
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictors of compliance with surveillance after endovascular aneurysm repair and comparative survival outcomes.
    Wu CY; Chen H; Gallagher KA; Eliason JL; Rectenwald JE; Coleman DM
    J Vasc Surg; 2015 Jul; 62(1):27-35. PubMed ID: 25864044
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A note on estimating treatment effect for time-to-event data in a literature-based meta-analysis.
    Hirooka T; Hamada C; Yoshimura I
    Methods Inf Med; 2009; 48(2):104-12. PubMed ID: 19283306
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.